Annual EPS
-$26.75
+$1.95+6.79%
December 31, 2023
Summary
- As of February 12, 2025, CYCC annual earnings per share is -$26.75, with the most recent change of +$1.95 (+6.79%) on December 31, 2023.
- During the last 3 years, CYCC annual EPS has risen by +$24.55 (+47.86%).
- CYCC annual EPS is now -3666.67% below its all-time high of $0.75, reached on January 1, 1994.
Performance
CYCC EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.18
+$0.54+75.00%
September 30, 2024
Summary
- As of February 12, 2025, CYCC quarterly earnings per share is -$0.18, with the most recent change of +$0.54 (+75.00%) on September 30, 2024.
- Over the past year, CYCC quarterly EPS has increased by +$6.05 (+97.11%).
- CYCC quarterly EPS is now -100.05% below its all-time high of $360.00, reached on June 30, 2013.
Performance
CYCC Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$9.40
+$0.30+3.09%
September 30, 2024
Summary
- As of February 12, 2025, CYCC TTM earnings per share is -$9.40, with the most recent change of +$0.30 (+3.09%) on September 30, 2024.
- Over the past year, CYCC TTM EPS has increased by +$10.88 (+53.65%).
- CYCC TTM EPS is now at all-time high.
Performance
CYCC TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
CYCC EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.8% | +97.1% | +53.6% |
| 3 y3 years | +47.9% | +97.4% | +68.0% |
| 5 y5 years | +85.6% | +97.4% | +68.0% |
CYCC EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +14.7% | at high | +98.0% | at high | +70.7% |
| 5 y | 5-year | at high | +81.9% | at high | +99.6% | at high | +93.7% |
| alltime | all time | -3666.7% | +100.0% | -100.0% | +100.0% | at high | +100.0% |
Cyclacel Pharmaceuticals EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.18(-75.0%) | -$9.40(-3.1%) |
| Jun 2024 | - | -$0.72(-68.3%) | -$9.70(-37.6%) |
| Mar 2024 | - | -$2.27(-63.6%) | -$15.55(-23.3%) |
| Dec 2023 | -$26.75(-6.8%) | -$6.23(+1197.9%) | -$20.28(-12.0%) |
| Sep 2023 | - | -$0.48(-92.7%) | -$23.05(-20.6%) |
| Jun 2023 | - | -$6.57(-6.1%) | -$29.02(-1.1%) |
| Mar 2023 | - | -$7.00(-22.2%) | -$29.35(+2.4%) |
| Dec 2022 | -$28.70(-8.5%) | -$9.00(+39.5%) | -$28.65(+3.2%) |
| Sep 2022 | - | -$6.45(-6.5%) | -$27.75(-5.6%) |
| Jun 2022 | - | -$6.90(+9.5%) | -$29.40(-4.9%) |
| Mar 2022 | - | -$6.30(-22.2%) | -$30.90(-3.7%) |
| Dec 2021 | -$31.35(-38.9%) | -$8.10(0.0%) | -$32.10(-27.2%) |
| Sep 2021 | - | -$8.10(-3.6%) | -$44.10(+2.4%) |
| Jun 2021 | - | -$8.40(+12.0%) | -$43.05(-0.7%) |
| Mar 2021 | - | -$7.50(-62.7%) | -$43.35(-25.3%) |
| Dec 2020 | -$51.30(-65.2%) | -$20.10(+185.1%) | -$58.05(-27.4%) |
| Sep 2020 | - | -$7.05(-19.0%) | -$79.95(-25.2%) |
| Jun 2020 | - | -$8.70(-60.8%) | -$106.95(-17.9%) |
| Mar 2020 | - | -$22.20(-47.1%) | -$130.20(-12.9%) |
| Dec 2019 | -$147.60(-20.6%) | -$42.00(+23.3%) | -$149.55(-5.7%) |
| Sep 2019 | - | -$34.05(+6.6%) | -$158.55(-11.2%) |
| Jun 2019 | - | -$31.95(-23.1%) | -$178.50(-8.2%) |
| Mar 2019 | - | -$41.55(-18.5%) | -$194.55(+2.9%) |
| Dec 2018 | -$186.00(-68.2%) | -$51.00(-5.6%) | -$189.00(-0.6%) |
| Sep 2018 | - | -$54.00(+12.5%) | -$190.14(-53.5%) |
| Jun 2018 | - | -$48.00(+33.3%) | -$409.14(-20.0%) |
| Mar 2018 | - | -$36.00(-31.0%) | -$511.14(-13.2%) |
| Dec 2017 | -$585.00(-44.3%) | -$52.14(-80.9%) | -$589.14(-20.8%) |
| Sep 2017 | - | -$273.00(+82.0%) | -$744.00(+2.1%) |
| Jun 2017 | - | -$150.00(+31.6%) | -$729.00(-17.3%) |
| Mar 2017 | - | -$114.00(-44.9%) | -$882.00(-18.3%) |
| Dec 2016 | -$1050.00(-34.7%) | -$207.00(-19.8%) | -$1080.00(-12.4%) |
| Sep 2016 | - | -$258.00(-14.9%) | -$1233.00(-2.1%) |
| Jun 2016 | - | -$303.00(-2.9%) | -$1260.00(-4.1%) |
| Mar 2016 | - | -$312.00(-13.3%) | -$1314.00(-22.1%) |
| Dec 2015 | -$1608.00(-49.8%) | -$360.00(+26.3%) | -$1686.00(-19.0%) |
| Sep 2015 | - | -$285.00(-20.2%) | -$2082.01(-19.6%) |
| Jun 2015 | - | -$357.00(-47.8%) | -$2589.01(-14.4%) |
| Mar 2015 | - | -$684.00(-9.5%) | -$3024.01(-6.7%) |
| Dec 2014 | -$3204.01(-30.5%) | -$756.00(-4.5%) | -$3240.01(+2.3%) |
| Sep 2014 | - | -$792.00(0.0%) | -$3168.01(-10.2%) |
| Jun 2014 | - | -$792.00(-12.0%) | -$3528.01(+48.5%) |
| Mar 2014 | - | -$900.00(+31.6%) | -$2376.01(-58.5%) |
| Dec 2013 | -$4608.02 | -$684.00(-40.6%) | -$5724.02(-16.3%) |
| Sep 2013 | - | -$1152.00(-420.0%) | -$6840.03(+3.8%) |
| Jun 2013 | - | $360.00(-108.5%) | -$6588.03(-23.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | -$4248.02(+136.0%) | -$8568.03(+48.7%) |
| Dec 2012 | -$6048.02(-24.3%) | -$1800.01(+100.0%) | -$5760.02(+0.6%) |
| Sep 2012 | - | -$900.00(-44.4%) | -$5724.02(-12.2%) |
| Jun 2012 | - | -$1620.01(+12.5%) | -$6516.03(-5.7%) |
| Mar 2012 | - | -$1440.01(-18.4%) | -$6912.03(-13.5%) |
| Dec 2011 | -$7992.03(-39.0%) | -$1764.01(+4.3%) | -$7992.04(+6.7%) |
| Sep 2011 | - | -$1692.01(-16.1%) | -$7488.02(-12.6%) |
| Jun 2011 | - | -$2016.01(-20.0%) | -$8568.03(-22.7%) |
| Mar 2011 | - | -$2520.01(+100.0%) | -$11.09 K(-15.4%) |
| Dec 2010 | -$13.10 K(-35.7%) | -$1259.99(-54.5%) | -$13.10 K(-20.1%) |
| Sep 2010 | - | -$2772.01(-38.9%) | -$16.39 K(-4.5%) |
| Jun 2010 | - | -$4536.02(0.0%) | -$17.16 K(-20.9%) |
| Mar 2010 | - | -$4536.02(-0.3%) | -$21.70 K(-8.8%) |
| Dec 2009 | -$20.37 K(-59.1%) | -$4548.48(+28.5%) | -$23.80 K(-18.1%) |
| Sep 2009 | - | -$3540.76(-61.0%) | -$29.05 K(-38.6%) |
| Jun 2009 | - | -$9076.54(+36.9%) | -$47.30 K(-3.1%) |
| Mar 2009 | - | -$6629.63(-32.4%) | -$48.81 K(-2.4%) |
| Dec 2008 | -$49.86 K(+67.9%) | -$9806.17(-55.0%) | -$49.99 K(-7.8%) |
| Sep 2008 | - | -$21.79 K(+105.8%) | -$54.20 K(+43.7%) |
| Jun 2008 | - | -$10.58 K(+35.5%) | -$37.71 K(+19.5%) |
| Mar 2008 | - | -$7812.04(-44.3%) | -$31.56 K(+5.9%) |
| Dec 2007 | -$29.70 K(-40.7%) | -$14.02 K(+164.9%) | -$29.79 K(+22.0%) |
| Sep 2007 | - | -$5292.03(+19.2%) | -$24.41 K(-11.8%) |
| Jun 2007 | - | -$4438.27(-26.6%) | -$27.69 K(-18.8%) |
| Mar 2007 | - | -$6044.50(-30.0%) | -$34.08 K(-26.3%) |
| Dec 2006 | -$50.05 K(-18.6%) | -$8634.95(+0.8%) | -$46.21 K(-34.4%) |
| Sep 2006 | - | -$8568.04(-20.9%) | -$70.46 K(-13.3%) |
| Jun 2006 | - | -$10.83 K(-40.4%) | -$81.30 K(+0.7%) |
| Mar 2006 | - | -$18.17 K(-44.7%) | -$80.77 K(+10.2%) |
| Dec 2005 | -$61.50 K(-2.1%) | -$32.89 K(+69.5%) | -$73.29 K(+43.0%) |
| Sep 2005 | - | -$19.40 K(+88.4%) | -$51.25 K(+17.9%) |
| Jun 2005 | - | -$10.30 K(-3.7%) | -$43.46 K(-0.1%) |
| Mar 2005 | - | -$10.70 K(-1.4%) | -$43.51 K(-45.1%) |
| Dec 2004 | -$62.82 K(+99.5%) | -$10.85 K(-6.6%) | -$79.25 K(+2.3%) |
| Sep 2004 | - | -$11.62 K(+12.2%) | -$77.43 K(+6.7%) |
| Jun 2004 | - | -$10.35 K(-77.7%) | -$72.60 K(+1.7%) |
| Mar 2004 | - | -$46.43 K(+414.1%) | -$71.37 K(+126.6%) |
| Dec 2003 | -$31.50 K(-32.8%) | -$9032.42(+33.2%) | -$31.50 K(+40.2%) |
| Sep 2003 | - | -$6783.28(-25.6%) | -$22.46 K(+43.3%) |
| Jun 2003 | - | -$9122.87(+39.1%) | -$15.68 K(+139.1%) |
| Mar 2003 | - | -$6558.02 | -$6558.02 |
| Dec 2002 | -$46.85 K(-1.7%) | - | - |
| Dec 2001 | -$47.65 K(+115.8%) | - | - |
| Dec 2000 | -$22.08 K(<-9900.0%) | - | - |
| Jan 1994 | $0.75(+48.5%) | - | - |
| Jan 1993 | $0.51 | - | - |
FAQ
- What is Cyclacel Pharmaceuticals annual earnings per share?
- What is the all time high annual EPS for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals annual EPS year-on-year change?
- What is Cyclacel Pharmaceuticals quarterly earnings per share?
- What is the all time high quarterly EPS for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly EPS year-on-year change?
- What is Cyclacel Pharmaceuticals TTM earnings per share?
- What is the all time high TTM EPS for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals TTM EPS year-on-year change?
What is Cyclacel Pharmaceuticals annual earnings per share?
The current annual EPS of CYCC is -$26.75
What is the all time high annual EPS for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual earnings per share is $0.75
What is Cyclacel Pharmaceuticals annual EPS year-on-year change?
Over the past year, CYCC annual earnings per share has changed by +$1.95 (+6.79%)
What is Cyclacel Pharmaceuticals quarterly earnings per share?
The current quarterly EPS of CYCC is -$0.18
What is the all time high quarterly EPS for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly earnings per share is $360.00
What is Cyclacel Pharmaceuticals quarterly EPS year-on-year change?
Over the past year, CYCC quarterly earnings per share has changed by +$6.05 (+97.11%)
What is Cyclacel Pharmaceuticals TTM earnings per share?
The current TTM EPS of CYCC is -$9.40
What is the all time high TTM EPS for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high TTM earnings per share is -$9.40
What is Cyclacel Pharmaceuticals TTM EPS year-on-year change?
Over the past year, CYCC TTM earnings per share has changed by +$10.88 (+53.65%)